title: Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Hugo M
authors.initials: HM
authors.lastname: Horlings
authors.affiliation: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada2Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3Department of Computer Science, Univ.
authors.forename: Sohrab P
authors.initials: SP
authors.lastname: Shah
authors.affiliation: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada2Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada4Department of Obstetrics and Gynecol.
authors.forename: David G
authors.initials: DG
authors.lastname: Huntsman
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics*; D004252:DNA Mutational Analysis; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D020022:Genetic Predisposition to Disease; D006801:Humans; D058990:Molecular Targeted Therapy; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D018579:Patient Selection; D010641:Phenotype; D057285:Precision Medicine; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor